Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Ladenburg Thalmann Healthcare Conference
 Tuesday, July 13, 2021
 11:00am EDT